查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842198

體液採集與診斷市場規模、佔有率及趨勢分析報告：依樣本、產品、技術、應用、地區及細分市場預測，2025-2033年

Body Fluid Collection And Diagnostics Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

體液採集與診斷市場摘要

全球體液採集和診斷市場預計在 2024 年達到 343.5 億美元，預計到 2033 年將達到 619.9 億美元，2025 年至 2033 年的複合年成長率為 6.87%。

快速出結果、成本效益高、疾病早期預後好，這些都是推動體液採集和診斷產業發展的因素。

體外診斷技術的進步也發揮著重要作用，使檢測更加準確高效，從而促進了其更廣泛的應用。例如，2022年5月，TECHKON GmbH推出了一種新的體液分析方法，可同時評估各項醫學參數並診斷疾病，使檢測速度更快、更全面。

血液相關疾病的增加是推動血液採集設備需求成長的主要因素。貧血、鐮狀細胞貧血、血友病和凝血障礙等疾病以及骨髓瘤、淋巴瘤和白血病等血液癌症的發生率都在增加。在美國，血液癌症尤其具有毀滅性，平均每九分鐘就有一人死於血液癌症，這意味著每天約有157人死亡，每小時超過六人死亡。預計到2023年，美國將有57,380人死於白血病、淋巴瘤和骨髓瘤，約佔所有癌症相關死亡人數的9.4%。

據估計，美國約有437,337人患有白血病或處於白血病緩解期，約有879,242人患有淋巴瘤。血栓每年影響約90萬美國人，並導致約10萬人死亡。值得注意的是，只有不到四分之一的人會出現明顯的血栓徵兆或症狀，這凸顯了這種疾病的隱匿性及其帶來的重大影響。

人們對疾病早期檢測的日益關注顯著推動了體液採集和診斷行業的需求。唾液、血液、尿液和精液等樣本擴大被用於分析生物標記和其他指標，以實現準確及時的診斷。此外，全球範圍內湧現許多技術進步和創新，進一步提升了檢測能力，並拓展了基於體液診斷的疾病檢測範圍。例如，2021年7月，雅培宣佈在印度推出Panbio COVID-19抗原自我檢測試劑盒，進一步豐富了其快速診斷產品系列。本產品可滿足職場、診所和家庭的檢測需求。最近，2024年5月，由Terumo Corporation開發的Rika血漿捐贈系統（採用iNomi列線圖）獲得美國FDA核准。本產品可根據捐贈者捐血時的體重、身高及血球比容值，以確定需要採集的血漿量。

阿茲海默症（AD）是一種嚴重的神經退化性疾病，因此亟需尋找準確的生物標記。早期生物標記的開發和檢驗是現有AD診斷方法的重要研究方向。體液生物標記能夠準確反映大腦中的突觸損傷，因此可能有助於提高診斷準確性、追蹤疾病進程以及評估早期疾病修正治療的療效。 2022年5月，美國食品藥物管理局（FDA）批准了一種可能改善AD診斷的新型檢測方法上市。 Lumipulse檢測評估人類腦脊髓液（CSF）中澱粉樣蛋白1-40與澱粉樣蛋白1-42的濃度比值，可以幫助醫生判斷患者是否有形成澱粉樣蛋白的風險，而澱粉樣蛋白斑塊則是AD的標誌性症狀。

體液樣本中含有多種天然生物標記蛋白，這些蛋白質能夠有效指示癌症的進展。體液樣本也可用於檢測這些生物標記，從而確診癌症。例如，2022年1月，伊利諾大學的科學家開發了一種能夠從體液樣本中檢測癌症生物標記的工具。對體液中此類癌症相關分子生物標記進行定量和檢測，可能有助於實現微創癌症檢測。

此外，體外診斷領域的技術創新，例如高通量檢測、自動化和人工智慧的整合，正在顯著提高診斷的準確性和效率。這些進步實現了更快的檢測週期和更高的靈敏度，使體液診斷工具成為現代醫療保健中不可或缺的一部分。這些創新解決方案的出現正在推動這些技術在全球範圍內的應用。

全球體液採集與診斷市場區隔

該報告預測了2021年至2033年全球、區域和國家層面的收入成長，並分析了各細分市場的產業趨勢。為了便於研究，Grand View Research根據樣本、技術、應用、產品和地區對全球體液採集和診斷市場報告進行了細分：

  • 按樣本分類的展望（收入，2021-2033 年）
  • 血
  • 唾液
  • 尿
  • 腦脊髓液
  • 按產品分類的展望（收入，2021-2033 年）
  • 檢查/服務
  • 套件和耗材
  • 檢測設備
  • 按技術分類的展望（收入，2021-2033 年）
  • 下一代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 螢光雜合反應螢光（FISH）
  • 其他
  • 按應用領域分類的展望（收入，2021-2033 年）
  • 診斷和監測
  • 治療決策
  • 預後診斷和篩檢
  • 區域展望（收入，2021-2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 體液採集與診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 體液採集與診斷市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 體液採集與診斷市場：樣本估算與趨勢分析

  • 按樣本分類的市場佔有率，2024 年和 2033 年
  • 細分儀表板
  • 全球體液採集與診斷市場展望（依樣本分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 血
  • 唾液
  • 尿
  • 腦脊髓液

第5章：體液採集與診斷市場：依產品分類的估算與趨勢分析

  • 按產品分類的市場佔有率，2024 年和 2033 年
  • 細分儀表板
  • 全球體液採集與診斷市場展望（依產品分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 測試/服務
  • 套件和耗材
  • 裝置

第6章：體液採集與診斷市場：依技術分類的估算與趨勢分析

  • 按技術分類的市場佔有率，2024 年和 2033 年
  • 細分儀表板
  • 全球體液採集與診斷市場展望（依技術分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 次世代定序
  • 聚合酵素鏈鎖反應（PCR）
  • 螢光雜合反應螢光（FISH）
  • 其他

第7章：體液採集與診斷市場：按應用分類的估算與趨勢分析

  • 按應用領域分類的市場佔有率，2024 年和 2033 年
  • 細分儀表板
  • 全球體液採集與診斷市場展望（按應用領域分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 診斷和監測
  • 治療決策
  • 預後和篩檢

第8章：體液採集與診斷市場：區域估算與趨勢分析

  • 2024 年及 2033 年各地區市佔率分析
  • 區域市場概覽
  • 區域市場概況
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業市佔率分析，2024 年
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories
    • Illumina, Inc
    • Guardant Health
    • QIAGEN
    • Johnson &Johnson
    • Laboratory Corporation of America Holdings
    • Biocept Inc
    • F. Hoffmann-La Roche Ltd.
    • MDxHealth SA.
Product Code: GVR-4-68040-019-8

Body Fluid Collection And Diagnostics Market Summary

The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is anticipated to reach USD 61.99 billion by 2033, growing at a CAGR of 6.87% from 2025 to 2033. Rapid results, cost-effectiveness, and early prognosis of diseases are some of the factors contributing to the growth of the body fluid collection and diagnostics industry.

Advances in in-vitro diagnostic techniques are also playing a big role, as they make testing more accurate and efficient, encouraging wider use. For instance, in May 2022, TECHKON GmbH introduced a new method for analyzing body fluids that can assess medical parameters and diagnose diseases at the same time, making testing faster and more comprehensive.

The growing number of blood-related disorders is a key factor driving the demand for blood collection devices. Diseases such as anemia, sickle cell disease, hemophilia, and clotting disorders are becoming more common, along with blood cancers such as myeloma, lymphoma, and leukemia. In the U.S., blood cancer is particularly devastating, taking a life every nine minutes, which adds up to about 157 deaths each day or more than six every hour. In 2023, it's estimated that nearly 57,380 people in the U.S. will die from leukemia, lymphoma, or myeloma, accounting for almost 9.4% of all cancer-related deaths.

An estimated 437,337 individuals in the U.S. are either living with or in remission from leukemia, while around 879,242 people are in the same condition with lymphoma. Blood clots affect approximately 900,000 Americans each year, leading to about 100,000 deaths annually. Notably, fewer than one in four people show any noticeable signs or symptoms of a blood clot, underscoring the silent but significant impact of this condition.

The growing focus on early disease detection has significantly driven demand in the body fluid collection and diagnostics industry. Samples such as saliva, blood, urine, and semen are increasingly used to analyze biomarkers and other indicators for accurate and timely diagnosis. Moreover, numerous advancements and innovations have been made globally, further enhancing testing capabilities and expanding the range of conditions that can be detected through fluid-based diagnostics. For instance, in July 2021, Abbott announced of launching Panbio COVID-19 Antigen Self-Test in India to strengthen its rapid diagnostics product portfolio. It would support testing needs at work, at clinics, and at home. Further recently, In May 2024, the U.S. FDA approved the Rika Plasma Donation System featuring the iNomi Nomogram developed by Terumo Corporation. This product helps determine plasma collection volume based on an individual donor's weight, height, and hematocrit level at the time of donation.

Alzheimer's Disease (AD) is a severe neurodegenerative disease that requires the identification of precise biomarkers. The development and validation of early-stage biomarkers is a high research priority for existing diagnostics that can detect AD. Body-fluid biomarkers accurately reflect a synaptic failure in the brain and, as a result, could help improve diagnostic accuracy, track the course of the disease, and act as indicators for evaluating the effectiveness of early-onset disease-modifying therapies. In May 2022, the FDA authorized the marketing of a new test that could improve the diagnosis of AD. The Lumipulse test evaluates the ratio of -amyloid 1-40 and-amyloid 1-42 concentrations found in the human cerebral spinal fluid, which can help doctors in determining if a patient is expected to have amyloid plaques, a characteristic symptom of AD.

Body fluid samples contain a large number of naturally occurring biomarker proteins, which effectively show cancer progression. They are also utilized to find these biomarkers in order to validate the presence of cancer. For instance, in January 2022, scientists from the University of Illinois developed a tool that could detect cancer biomarkers in the body fluid samples. The quantification and detection of cancer-associated molecular biomarkers in such body fluids would help for minimally invasive cancer detection.

Furthermore, technological innovations in in-vitro diagnostics, such as high-throughput testing, automation, and integration of AI, have significantly enhanced diagnostic accuracy and efficiency. These advancements enable faster turnaround times and improved sensitivity, making body fluid diagnostic tools indispensable for modern healthcare. The availability of such innovative solutions supports the global adoption of these technologies.

Global Body Fluid Collection And Diagnostics Market Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global body fluid collection and diagnostics market report on the basis of sample, technology, application, product and region:

  • Sample Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood
  • Saliva
  • Urine
  • Cerebrospinal Fluid
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tests/Services
  • Kits & Consumables
  • Instruments
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence in situ hybridization (FISH)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics & Monitoring
  • Therapeutic Decision Making
  • Prognostics & Screening
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Sample
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. Application
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Sample Outlook
    • 2.2.2. Product outlook
    • 2.2.3. Technology outlook
    • 2.2.4. Application outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Body Fluid Collection And Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing adoption of body fluid and collection kits for rapid diagnosis
      • 3.2.1.2. Increasing prevalence of non-communicable diseases
      • 3.2.1.3. Technological Advancements in Diagnostic Testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of expertise to conduct at-home testing
      • 3.2.2.2. High cost of instruments
  • 3.3. Body Fluid Collection And Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Body Fluid Collection And Diagnostics Market: Sample Estimates & Trend Analysis

  • 4.1. Sample Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Body Fluid Collection And Diagnostics Market by Sample Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Blood
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 4.6. Saliva
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Urine
    • 4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Cerebrospinal Fluid
    • 4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Body Fluid Collection And Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Body Fluid Collection And Diagnostics Market by Product Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Tests/Services
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 5.6. Kits & Consumables
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Instruments
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Body Fluid Collection And Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Body Fluid Collection And Diagnostics Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Next-Generation Sequencing
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.6. Polymerase Chain Reaction (PCR)
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Fluorescence in situ hybridization (FISH)
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Body Fluid Collection And Diagnostics Market: Application Estimates & Trend Analysis

  • 7.1. Application Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Body Fluid Collection And Diagnostics Market by Application Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Diagnostics & Monitoring
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 7.6. Therapeutic Decision Making
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Prognostics & Screening
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Body Fluid Collection And Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. Thermo Fisher Scientific Inc.
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Bio-Rad Laboratories
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Illumina, Inc
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Guardant Health
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. QIAGEN
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Johnson & Johnson
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Laboratory Corporation of America Holdings
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Biocept Inc
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. F. Hoffmann-La Roche Ltd.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. MDxHealth SA.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 4 Global body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 Global body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 6 Global body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 7 North America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 9 North America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 10 North America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 11 North America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 13 U.S. body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 U.S. body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S. body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Canada body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 17 Canada body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 Canada body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Canada body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 20 Mexico body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 21 Mexico body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Mexico body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Mexico body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 24 Europe body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 26 Europe body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 27 Europe body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Europe body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 29 Germany body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 30 Germany body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 31 Germany body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Germany body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 34 UK body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 35 UK body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 36 UK body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 38 France body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 39 France body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 40 France body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Italy body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 42 Italy body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 43 Italy body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Italy body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Spain body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 46 Spain body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 47 Spain body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Spain body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Denmark body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 50 Denmark body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 51 Denmark body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Denmark body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 54 Sweden body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 55 Sweden body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Sweden body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Norway body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 58 Norway body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 59 Norway body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Norway body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 66 China body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 67 China body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 68 China body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 69 China body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 70 Japan body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 71 Japan body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 72 Japan body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 73 Japan body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 74 India body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 75 India body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 76 India body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 77 India body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 78 South Korea body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 79 South Korea body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 80 South Korea body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 81 South Korea body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 82 Australia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 83 Australia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 84 Australia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Australia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 87 Thailand body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 88 Thailand body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 99 Thailand body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 100 Latin America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 101 Latin America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 102 Latin America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Latin America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 104 Latin America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 105 Brazil body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 106 Brazil body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 107 Brazil body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 108 Brazil body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 109 Argentina body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 110 Argentina body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 111 Argentina body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 112 Argentina body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 113 Middle East & Africa body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 114 Middle East & Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 115 Middle East & Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Middle East & Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 117 Middle East & Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 118 South Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 119 South Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 South Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 121 South Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 122 Saudi Arabia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 123 Saudi Arabia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Saudi Arabia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 125 Saudi Arabia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 126 UAE body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 127 UAE body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 128 UAE body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 130 UAE body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Kuwait body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 132 Kuwait body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 133 Kuwait body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 134 Kuwait body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Body Fluid Collection And Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global body fluid collection and diagnostics market, Sample Movement Analysis
  • Fig. 16 Global body fluid collection and diagnostics market, for Blood, 2021 - 2033 (USD Million)
  • Fig. 17 Global body fluid collection and diagnostics market, for Urine, 2021 - 2033 (USD Million)
  • Fig. 18 Global body fluid collection and diagnostics market, for Saliva, 2021 - 2033 (USD Million)
  • Fig. 19 Global body fluid collection and diagnostics market, for Cerebrospinal Fluid, 2021 - 2033 (USD Million)
  • Fig. 20 Global body fluid collection and diagnostics market, Product Movement Analysis
  • Fig. 21 Global body fluid collection and diagnostics market, for Tests/Services, Movement Analysis
  • Fig. 22 Global body fluid collection and diagnostics market, for Kits & Consumables, 2021 - 2033 (USD Million)
  • Fig. 23 Global body fluid collection and diagnostics market, for Instruments, 2021 - 2033 (USD
  • Fig. 24 Global body fluid collection and diagnostics market, Technology Movement Analysis
  • Fig. 25 Global body fluid collection and diagnostics market, for Next Generation Sequencing, 2021 - 2033 (USD Million)
  • Fig. 26 Global body fluid collection and diagnostics market, for PCR - based Testing, 2021 - 2033 (USD Million)
  • Fig. 27 Global body fluid collection and diagnostics market, for FISH, 2021 - 2033 (USD Million)
  • Fig. 28 Global body fluid collection and diagnostics market, for Others, 2021 - 2033 (USD Million)
  • Fig. 29 Global body fluid collection and diagnostics market, Application Movement Analysis
  • Fig. 30 Global body fluid collection and diagnostics market, for Diagnostics & Monitoring, 2021 - 2033 (USD Million)
  • Fig. 31 Global body fluid collection and diagnostics market, for Therapeutic Decision Making, 2021 - 2033 (USD Million)
  • Fig. 32 Global body fluid collection and diagnostics market, for Prognostics & Screening, 2018- 2033 Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2024 & 2033
  • Fig. 35 Global Body Fluid Collection And Diagnostics Market, Region Movement Analysis
  • Fig. 36 North America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 38 Canada body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 41 Germany body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 UK body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 43 France body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Norway body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Japan body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 51 China body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 India body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 53 Australia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Middle East and Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 62 UAE body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait body fluid collection and diagnostics market, 2021 - 2033 (USD Million)